Donor stem cell transplant shown to improve survival in older patients with MDS

(Dana-Farber Cancer Institute) A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk myelodysplastic syndrome (MDS), Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news